VC Co-Working Day: Deep Tech x Bio
Join us for our next VC Co-Working Day (+ Deal Flow Breakfast), this time centered on Deep Tech x Bio - bringing together NYC’s early-stage investors backing breakthroughs across biology, engineering, AI, computation, chemistry, advanced manufacturing, materials science, and physical systems. From Pre-Seed to Series A, we welcome investors supporting innovations across deep tech x bio for meaningful deal-sharing, cross-disciplinary insight, and curated co-working.
You are welcome to RSVP for:
Both the Deal Flow Breakfast (9:00 - 10:30 AM) + VC Co-Working Day (10:30 AM–5:00 PM) OR
The VC Co-Working Day only (10:30 AM–5:00 PM)
Please select your preferred option when registering. This session is proudly sponsored by Wilson Sonsini.
Schedule:
9:00 - 10:30 AM | Deal Flow Breakfast: We’ll kick off the day with a curated breakfast for a select group of investors focused on Deep Tech x Bio to share and discuss live deals. If you sign up for the Deal Flow Breakfast, please be prepared to come with an active deal to share with the group.
10:30 AM - 5:00 PM | VC Co-Working: We are opening up our office to investors across our network for informal working time and deeper one-on-one conversations. You’ll find plenty of desks in our open-office space to settle in, as well as private huddle rooms available throughout the day for calls and meetings.
5:30 PM Onward | Evening Programming: For those who’d like to continue the conversation, we’re also hosting another evening session as part of NY Deep Tech Week: Plasma Beyond Fusion: Powering Next Generation Semiconductor Manufacturing & Materials. If you’d like to attend, please note that this requires a separate registration. You can find the event details and register here.
About our Sponsor and Partner
Wilson Sonsini has a 60-plus year history of representing trailblazers in the life sciences industry - from the earliest innovators to those that are shaping the future of healthcare today. We work closely with entrepreneurs, scientists, and investors who trust Wilson Sonsini’s strategic advice to establish and realize their companies’ business objectives, which includes protecting and leveraging their most valuable IP assets. We represent life sciences companies through the entire business life cycle, from formation through IPO and strategic partnerships. We often act as outside general counsel with support from our cross-functional, global life sciences team to provide coordinated and comprehensive counsel to clients.
Our clients include thousands of innovation-focused life sciences companies, research institutions, start-up accelerators and incubators, and the venture capital funds and banks that finance the industry. A central pillar of our life sciences practice is our longstanding representation of medical device and biopharmaceutical companies, entrepreneurs, and investors, which dates back to these industries’ inception.
Wilson Sonsini’s life sciences practice is anchored by a diverse team of attorneys, patent agents, and scientific advisors, more than 100 of whom hold Ph.D.s and have significant industry experience. The team also includes former in-house legal counsel for major life sciences companies, an internationally recognized leader in the field of technology transfer, and former senior officials at U.S. federal agencies, such as the U.S. Patent and Trademark Office (USPTO) and the Patent Trial and Appeal Board (PTAB).